There
is a growing trend in Ireland toward greater collaboration
between academia and the pharmaceutical industry. This is an activity
encouraged at a national policy level as a means of providing researchers
from academic institutions the opportunity to gain important first-hand
experience in a commercial research environment, while also providing
industry access to expertise and resources to develop new and improved
processes for timely medicines. The participating company benefits
in terms of its growth, the evolution of its strategic research and
development, and the creation of new knowledge that it can use to
generate commercial advantage. The research institute benefits in
terms of developing skill sets, intellectual property, and publications,
in addition to access to identified current industry challenges. A
case study is provided describing the collaborative partnership between
a synthetic chemistry research team at University College Cork (UCC)
and Eli Lilly and Company.